PubMed COVID-19 Clinical Care
7641 - 7650 of 8011 results found
Cerebrospinal fluid: a target of some fungi and an overview
Description
Meningitis is a potentially life-threatening infection characterised by the inflammation of the leptomeningeal membranes. The estimated annual prevalence of 8.7 million cases globally and the disease is caused by many different viral, bacterial, and
Consistent neutralization of circulating omicron sub-variants by hybrid immunity up to 6 months after booster vaccination
Description
The current COVID-19 vaccination program requires frequent booster vaccination to maintain sufficient neutralization levels against immune evasive SARS-CoV-2 variants. However, prior studies found more potent and durable immune response in
Clinical pearls and pitfalls of SARS-CoV-2 serology
Description
No abstract
Changes over Time in COVID-19 Vaccination Inequalities in Eight Large U.S. Cities
Description
The authors estimate the associations between community socioeconomic composition and changes in coronavirus disease 2019 (COVID-19) vaccination levels in eight large cities at three time points. In March, communities with high socioeconomic status
COVID-19-Associated Pulmonary Aspergillosis Isolates Are Genomically Diverse but Similar to Each Other in Their Responses to Infection-Relevant Stresses
Description
Secondary infections caused by the pulmonary fungal pathogen Aspergillus fumigatus are a significant cause of mortality in patients with severe coronavirus disease 19 (COVID-19). Even though epithelial cell damage and aberrant cytokine responses have
Comparison of circulating bacterial profiles between mild and severe COVID-19 patients
Description
Recent reports revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients can develop bacteremia; however, the circulating bacterial profile is not well studied. Therefore, this study has aimed to investigate
Clinical features of children with coronavirus disease 2019 caused by Delta variant infection in different age groups
Description
CONCLUSIONS: The clinical features of COVID-19 caused by Delta variant infection in children of different age groups may be different: children aged <6 years tend to develop myocardial injury, and those aged 6-13 years have fever except cough and expectoration and tend to develop renal and immune dysfunction.
